STOCK TITAN

Marsh Form 4 Filings

MRSH NYSE

Every Form 4 that Marsh (MRSH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MRSH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MRSH filings page.

Rhea-AI Summary

Marsh & McLennan Companies SVP and Chief Information Officer Paul Beswick reported routine equity compensation activity. On vesting, 6,970 restricted stock units converted into an equal number of common shares on a 1-for-1 basis. Of these, 3,403 shares were withheld by the company to cover applicable taxes, leaving Beswick with 17,089 shares of common stock held directly.

Rhea-AI Summary

Marsh & McLennan Companies SVP and General Counsel Katherine Brennan reported the vesting of 6,970 restricted stock units into common stock. The units, which relate to performance stock units granted on February 23, 2023 for the 2023-2025 performance period, converted to common stock on a 1-for-1 basis on February 28, 2026.

Of these 6,970 shares, 3,855 common shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share to cover applicable taxes, reflecting a tax-withholding disposition rather than an open-market sale. Following these transactions, Brennan directly owns 7,330 shares of Marsh & McLennan Companies common stock.

Rhea-AI Summary

Marsh & McLennan Companies President and CEO John Q. Doyle reported equity compensation activity involving restricted stock units and common stock. On February 28, 2026, 59,510 restricted stock units vested and converted into an equal number of Marsh & McLennan common shares on a 1-for-1 basis. To cover applicable taxes on this vesting, 30,380 common shares were withheld by the company at a price of $186.74 per share. After these transactions, Doyle directly owned 116,811.0205 shares of common stock.

Rhea-AI Summary

Marsh & McLennan Companies executive Carmen Fernandez, SVP and Chief People Officer, reported equity award activity tied to previously granted performance stock units. On February 28, 2026, 6,970 restricted stock units vested and converted into common shares on a 1-for-1 basis. Of these, 3,855 shares of common stock were withheld by the company to cover applicable taxes at a price of $186.74 per share, a tax-withholding disposition rather than an open-market sale. Following these transactions, Fernandez directly owned 12,995 shares of common stock, and indirectly held 282.917 shares through the Marsh & McLennan Companies 401(k) Savings & Investment Plan, based on the plan statement as of February 28, 2026.

Rhea-AI Summary

Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported equity award activity involving restricted stock units and common stock. On February 28, 2026, 4,826 restricted stock units converted into common shares on a 1-for-1 basis, reflecting vesting of performance stock units granted on February 23, 2023 for the 2023–2025 performance period.

Of these shares, 2,464 common shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share to cover applicable taxes. After these transactions, Jones directly held 10,340 common shares and 140.602 restricted stock units under the Supplemental Savings & Investment Plan.

In addition, 1,819.885 common shares were held indirectly through the Marsh & McLennan Companies 401(k) Savings & Investment Plan, with the plan custodian acquiring shares at prevailing market prices as of February 28, 2026.

Rhea-AI Summary

Marsh & McLennan Companies executive Dean Michael Klisura reported equity compensation activity involving restricted stock units and common shares. On February 28, 2026, 9,383 restricted stock units vested and converted into an equal number of common shares on a 1‑for‑1 basis. Of these, 5,189 shares were withheld by the company at a price of $186.74 per share to cover taxes, leaving the remainder added to his directly held common stock, which totaled 25,129.48 shares after the tax withholding. He also reported 1,679.724 restricted stock units under the Supplemental Savings & Investment Plan, reflecting additional units acquired by the plan custodian at prevailing market prices as of that date.

Rhea-AI Summary

Marsh & McLennan Companies Chief Financial Officer Mark C. McGivney reported the vesting and distribution of 17,961 restricted stock units that convert into common stock on a 1-for-1 basis. These units relate to performance stock units granted on February 23, 2023 for the 2023-2025 performance period.

Of the 17,961 resulting common shares, 9,170 shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share to cover applicable taxes. Following these transactions, McGivney directly holds 42,469 shares of common stock.

Rhea-AI Summary

Marsh & McLennan Companies President & CEO of Marsh Risk, South Martin, reported equity compensation activity. On the transaction date, 14,476 restricted stock units vested and converted into the same number of common shares on a 1-for-1 basis. Of these, 8,006 shares were withheld by the company at a price of $186.74 per share to cover applicable taxes, classified as a tax-withholding disposition rather than an open-market sale. The vested units relate to performance stock units granted on February 23, 2023 for the 2023-2025 performance period. Following these transactions, Martin directly held 23,650.539 common shares, which includes 118.022 shares acquired under the employee stock purchase plan for several quarters in 2025.

Rhea-AI Summary

Marsh & McLennan Companies, Inc. executive Nicholas Mark Studer reported the vesting of restricted stock units that converted into common stock. On February 28, 2026, 8,044 restricted stock units tied to performance for 2023–2025 were exercised on a 1‑for‑1 basis into 8,044 shares of common stock at no cash exercise price. Following this conversion, Studer directly owned 36,373 shares of Marsh & McLennan common stock.

Rhea-AI Summary

Marsh & McLennan Companies President and Mercer CEO Patrick Tomlinson reported the vesting of restricted stock units and related tax withholding. On the transaction date, 2,219 restricted stock units vested and converted into an equal number of common shares on a 1-for-1 basis. To cover applicable taxes, 1,134 of these shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share, leaving the remainder delivered to Tomlinson. After these transactions, he directly owned 3,655 shares of common stock and 6,082 restricted stock units.

Rhea-AI Summary

Marsh & McLennan Companies Chief Financial Officer receives new equity awards. On February 24, 2026, Mark C. McGivney was granted stock options for 44,743 shares at no cost and 17,961 restricted stock units, both held directly.

The options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030. Both the options and restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. The restricted stock units relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.

Rhea-AI Summary

Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick acquired equity awards on February 24, 2026. He received 22,372 stock options that vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

Beswick also acquired 6,970 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both the options and units convert into common stock on a 1‑for‑1 basis.

Rhea-AI Summary

Marsh & McLennan Companies senior vice president and general counsel Katherine Brennan reported equity awards on common stock. She received stock options for 22,372 shares, which were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

She was also granted 6,970 restricted stock units that convert into common stock on a 1-for-1 basis. These RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.

Rhea-AI Summary

Marsh & McLennan Companies reported an equity award for SVP and Chief People Officer Carmen Fernandez. She acquired stock options for 18,643 shares at no cost, vesting in four equal annual installments from February 24, 2027 through February 24, 2030. She also acquired 6,970 restricted stock units that convert into common stock on a 1-for-1 basis and relate to performance stock units originally granted for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.

Rhea-AI Summary

Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received new equity awards. On February 24, 2026 he was granted 15,536 stock options, which vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

He also acquired 4,826 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both instruments convert into Marsh & McLennan common stock on a 1‑for‑1 basis.

Rhea-AI Summary

MARSH & MCLENNAN COMPANIES reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received new equity awards. He was granted 24,858 stock options that were awarded on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030. The options convert into common stock on a 1-for-1 basis.

He also acquired 9,383 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both holdings are reported as directly owned.

Rhea-AI Summary

Marsh & McLennan Companies President and CEO John Q. Doyle reported two equity awards. He acquired 217,501 stock options on February 24, 2026 at a grant price of $0.00 per option. These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

He also acquired 59,510 restricted stock units on February 24, 2026. These RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both instruments convert into common stock on a 1-for-1 basis.

Rhea-AI Summary

Marsh & McLennan Companies executive equity awards: South Martin, President & CEO of Marsh Risk, received stock options for 39,772 shares and 14,476 restricted stock units on February 24, 2026. The options were granted at a price of $0.00 per share.

The options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030 and convert into common stock on a 1-for-1 basis. The restricted stock units relate to performance stock units granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.

Rhea-AI Summary

Marsh & McLennan Companies executive Nicholas Mark Studer reported equity awards rather than open‑market trades. He received stock options covering 21,129 shares of Marsh & McLennan common stock at an exercise price of $0.0000 per share. These options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

He was also granted 8,044 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. The performance factor for these units was determined on February 24, 2026, and both the options and units convert into Marsh & McLennan common stock on a 1‑for‑1 basis.

Rhea-AI Summary

Marsh & McLennan Companies Vice President and Controller Stacy Mills reported equity awards that increase her direct incentive stake in the company. On February 24, 2026, she was granted stock options for 3,574 shares at a price of $0.00 per share.

These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030 and convert into common stock on a 1-for-1 basis. On the same date, she also acquired restricted stock units of 1,342 and 1,625 shares under prior and new awards, with the earlier grant tied to 2023–2025 performance and the newer grant vesting in three equal installments on February 28 of 2027, 2028 and 2029.

Rhea-AI Summary

Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported new equity awards. He received 28,586 stock options that were granted on February 24, 2026 and will vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.

Tomlinson was also granted 1,609 restricted stock units tied to performance stock units originally awarded on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both instruments convert into Marsh & McLennan common stock on a 1-for-1 basis.

Rhea-AI Summary

Marsh & McLennan Companies director Morton O. Schapiro reported compensation-related equity activity in company stock units. He acquired 237.74 restricted stock units on February 15, 2026 as a grant, and 456.03 units on February 13, 2026 through dividend equivalents and director fees under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.

Rhea-AI Summary

Marsh & McLennan Companies director Anthony Anderson reported administrative updates to his equity holdings. On February 13, 2026, an entry labeled as an “other” transaction involved 80.98 restricted stock units under the Directors Stock Plan, tied to a reference price of $172.98 per unit.

Footnotes explain these restricted stock units accrue from dividend equivalents and convert into common stock on a 1-for-1 basis. Following these updates, Anderson reported 15,644.66 restricted stock units and 2,014.102 common shares held directly. The activity reflects plan-related credits rather than open-market buying or selling.

Rhea-AI Summary

MARSH & MCLENNAN COMPANIES director Deborah C. Hopkins reported an administrative equity adjustment. On February 13, 2026, she had 103.28 restricted stock units credited to her account as dividend equivalents under the Directors Stock Compensation Plan. These restricted stock units convert into common stock on a 1-for-1 basis, bringing her directly held restricted stock unit balance to 19,952.92 units following the transaction.

Rhea-AI Summary

Marsh & McLennan Companies director Tamara Ingram reported an automatic increase in equity-based compensation. She received 39.82 restricted stock units as dividend equivalents under the company’s Directors Stock Compensation Plan, each convertible into one share of common stock, bringing her directly held restricted stock units to 7,693.42.

Rhea-AI Summary

MARSH & MCLENNAN COMPANIES director Lloyd M. Yates reported stock-based compensation activity involving restricted stock units that convert into common shares on a 1-for-1 basis. On February 15, he received 208.92 restricted stock units at a reference price of $173.51 per unit as a grant under the Directors Stock Compensation Plan. On February 13, an additional 54.59 restricted stock units at $172.98 per unit were credited as dividend equivalents and director fee-related awards. Following these transactions, his directly held restricted stock units totaled 10,755.18.

Rhea-AI Summary

Marsh & McLennan Companies director Jane H. Lute reported new equity-based compensation in the form of restricted stock units. On February 15, 2026, she acquired 156.69 restricted stock units at $173.51 per unit as a grant or award, bringing her direct holdings to 7,351.38 units.

On February 13, 2026, an additional 37.24 units at $172.98 were credited as an "other" transaction, tied to dividend equivalents and director fees under the company’s Directors Stock Compensation Plan. Each restricted stock unit converts into one share of Marsh & McLennan Companies common stock.

Rhea-AI Summary

Marsh & McLennan Companies director Jan Siegmund reported a small change in his equity holdings. On February 13, 2026, he received 4.88 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan as dividend equivalents credited to his account.

The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Siegmund directly holds a total of 943.13 restricted stock units under this plan.

Rhea-AI Summary

Marsh & McLennan Companies director Steven A. Mills received a stock grant of common shares as part of his board compensation. On February 15, 2026, he acquired 244 shares of common stock at a reference value of $173.51 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this award, he directly owned 4,144.75 common shares. A separate line also reports 47,553 common shares held indirectly by a trust.